About Event

4th Lipid Nanoparticle Development Summit Europe- What Was It About?

As LNPs remains the delivery vehicle of choice for next-generation therapeutics, the 4th Lipid Nanoparticle Development Summit Europe provided three days of high-impact content. Over 80+ industry leaders joined together to tackle the toughest development challenges and explored the latest breakthroughs in LNP innovation, including:

  • Harnessing novel lipid designs to specifically target LNPs to your designated cell-type
  • Enhance LNP Stability to Support Thermostable, Scalable, and Globally Deployable Drug Products
  • Validating LNP potency and safety with rigorous preclinical models to streamline progression toward the clinic
  • Leveraging high-throughput automation to streamline LNP design and maximize therapeutic performance
  • Scaling your LNP drug product manufacturing effectively with GMP compliance, process efficiency and cost-effectiveness 
EVENT GUIDE

Unlock next-generation strategies to enhance LNP stability and achieve fridge-stable formulations that support global distribution and accessibility through innovations in lipid composition, encapsulation techniques, and degradation resistance for long-term therapeutic viability with insights from CureVac and SiSaf.

Enhance the precision delivery of LNP-based therapeutics by leveraging cutting-edge peptide engineering and nanoparticle design. Join Divincell and Leiden University to explore cell-type targeting and endosomal escape mechanisms for maximized intracellular delivery.

Gain practical, end-to-end insights into scaling LNP formulations for GMP manufacturing, from selecting scalable platform technologies and optimizing key process parameters to ensuring equipment flexibility and aligning with evolving regulatory expectations. Learn from real-world experiences shared by Sanofi and Fraunhofer IMM.

Accelerate LNP development with AI-driven insights to decode structure–function relationships, optimize lipid combinations, and streamline formulation decisions for improved delivery, stability, and clinical translation, with insights from CPI.

Uncover the potential of spray drying to create shelf-stable LNP therapeutics by addressing critical formulation and process development challenges, safeguarding fragile lipids and RNA payloads from thermal and mechanical stress, and enabling scalable, real-world manufacturing from lab to clinic with RNHale

2025 EVENT GUIDE
REGISTER INTEREST
PARTNER